INmune Bio Inc.

AI Score

0

Unlock

9.10
1.08 (13.47%)
At close: Jan 29, 2025, 3:59 PM
9.20
1.10%
After-hours Jan 29, 2025, 07:45 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -6.75 -3.97 -5.42 -17.06 -6.52 -7.21 -107.81 -323.05 -1.83K
PS Ratio 1.31K 303.90 909.01 18.91K 0.77 n/a n/a n/a n/a
PB Ratio 5.31 1.89 2.05 5.33 2.52 5.42 4.95 -600.81 -4.75K
P/FCF Ratio -16.9 -5.01 -3.78 -23.08 -11.07 -43.54 -104.01 -282.45 -4.95K
P/OCF Ratio -16.9 -5.01 -5.77 -23.08 -11.07 -43.54 -117.67 -282.45 -4.95K
OCF/S Ratio -77.29 -60.66 -157.48 -819.32 -0.07 n/a n/a n/a n/a
Debt / Equity Ratio 0.27 0.25 0.19 0.00 0.01 n/a n/a -2.35 n/a
Quick Ratio 2.16 5.92 20.21 1.15K 1.11K 1.03 6.13 0.75 0.39
Current Ratio 2.16 5.92 18.95 13.50 11.09 1.03 6.13 0.75 0.39
Asset Turnover 0.00 0.00 0.00 0.00 3.17 n/a n/a n/a n/a
Interest Coverage n/a -19.25 n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.79 -0.48 -0.38 -0.31 -0.39 -0.75 -0.05 1.86 2.59
Return on Assets (ROA) -0.53 -0.35 -0.3 -0.3 -0.37 -0.72 -0.05 -0.61 -4.11
Return on Capital (ROIC) -0.77 -0.37 -0.3 -0.31 -0.33 -0.75 -0.05 1.52 2.59
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 100.00% 100.00% 100.00% 100.00% n/a n/a n/a n/a
Net Profit Margin -19.36K% -7.66K% -16.76K% -110.84K% -11.77% n/a n/a n/a n/a
Pretax Profit Margin -19.36K% -7.30K% -16.76K% -110.84K% -9.88% n/a n/a n/a n/a
Operating Profit Margin -19.19K% -6.94K% -16.11K% -112.02K% -9.98% n/a n/a n/a n/a
FCF Margin -7.73K% -6.07K% -24.04K% -81.93K% -6.93% n/a n/a n/a n/a
EBITDA Margin -19.19K% n/a n/a n/a n/a n/a n/a n/a n/a